Lukáš Kielberger

676 total citations
12 papers, 109 citations indexed

About

Lukáš Kielberger is a scholar working on Epidemiology, Infectious Diseases and Psychiatry and Mental health. According to data from OpenAlex, Lukáš Kielberger has authored 12 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Psychiatry and Mental health. Recurrent topics in Lukáš Kielberger's work include SARS-CoV-2 and COVID-19 Research (3 papers), Neurological Complications and Syndromes (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). Lukáš Kielberger is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Neurological Complications and Syndromes (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). Lukáš Kielberger collaborates with scholars based in Czechia. Lukáš Kielberger's co-authors include Tomáš Reischig, Martin Kacer, Mirko Bouda, Jaromír Eiselt, Petr Pazdiora, Jaroslav Ráček, Stanislav Kormunda, Radek Kučera, Pavel Jindra and Jana Machová and has published in prestigious journals such as Transplantation, American Journal of Transplantation and Nephrology Dialysis Transplantation.

In The Last Decade

Lukáš Kielberger

10 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukáš Kielberger Czechia 7 58 45 12 11 10 12 109
Daniel Arroyo‐Sánchez Spain 6 134 2.3× 49 1.1× 8 0.7× 16 1.5× 5 0.5× 15 247
Noémie Lachaume France 4 51 0.9× 27 0.6× 13 1.1× 20 1.8× 12 1.2× 10 139
Christophe Masset France 8 110 1.9× 19 0.4× 10 0.8× 44 4.0× 16 1.6× 28 184
Karin Hu Austria 6 22 0.4× 20 0.4× 4 0.3× 11 1.0× 3 0.3× 11 87
Arnaud Guérard France 4 11 0.2× 22 0.5× 8 0.7× 11 1.0× 10 1.0× 4 91
Leela Morená United States 4 118 2.0× 9 0.2× 12 1.0× 12 1.1× 2 0.2× 15 148
Victor Augusto Hamamoto Sato Brazil 5 53 0.9× 52 1.2× 5 0.4× 26 2.4× 22 2.2× 13 119
Marie Le United States 5 85 1.5× 23 0.5× 24 2.0× 11 1.0× 8 0.8× 5 135
Carlijn Jordans Netherlands 5 55 0.9× 25 0.6× 6 0.5× 2 0.2× 8 0.8× 13 83
S. Reshwan K. Malahe Netherlands 5 59 1.0× 16 0.4× 16 1.3× 4 0.4× 1 0.1× 6 81

Countries citing papers authored by Lukáš Kielberger

Since Specialization
Citations

This map shows the geographic impact of Lukáš Kielberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukáš Kielberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukáš Kielberger more than expected).

Fields of papers citing papers by Lukáš Kielberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukáš Kielberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukáš Kielberger. The network helps show where Lukáš Kielberger may publish in the future.

Co-authorship network of co-authors of Lukáš Kielberger

This figure shows the co-authorship network connecting the top 25 collaborators of Lukáš Kielberger. A scholar is included among the top collaborators of Lukáš Kielberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukáš Kielberger. Lukáš Kielberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kacer, Martin, et al.. (2023). Safety and efficacy of one and two booster doses of SARS‐CoV‐2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial. Transplant Infectious Disease. 25(5). e14150–e14150. 5 indexed citations
2.
Reischig, Tomáš, Martin Kacer, Lukáš Kielberger, et al.. (2021). Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. American Journal of Transplantation. 22(3). 801–812. 33 indexed citations
3.
4.
Fiala, Ondřej, et al.. (2020). Nivolumab-induced hepatitis in a patient treated for malignant melanoma. 14(Suppl.B). 34–36.
5.
Eiselt, Jaromír, et al.. (2016). Previous Vaccination and Age are More Important Predictors of Immune Response to Influenza Vaccine than Inflammation and Iron Status in Dialysis Patients. Kidney & Blood Pressure Research. 41(2). 139–147. 8 indexed citations
6.
7.
Kielberger, Lukáš, et al.. (2015). FP529COMPARATIVE PERFORMANCE AND BIOCOMPATIBILITY ASSESSMENT STUDY OF A NEW HIGH-FLUX DIALYZER XEVONTA®. Nephrology Dialysis Transplantation. 30(suppl_3). iii249–iii249.
8.
Kacer, Martin, Lukáš Kielberger, Mirko Bouda, & Tomáš Reischig. (2015). Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective. Transplant Infectious Disease. 17(3). 334–341. 12 indexed citations
9.
Kacer, Martin, Lukáš Kielberger, Mirko Bouda, & Tomáš Reischig. (2014). Pharmacoeconomic Impact of Valganciclovir Versus Valacyclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients: A Randomized Controlled Trial.. Transplantation. 98. 763–763. 2 indexed citations
10.
Ráček, Jaroslav, et al.. (2013). Relationship between hepcidin and ferritin in haemodialysed patients. Wiener klinische Wochenschrift. 125(15-16). 448–452. 6 indexed citations
11.
Kielberger, Lukáš, Mirko Bouda, Pavel Jindra, & Tomáš Reischig. (2012). Pharmacoeconomic Impact of Different Regimens to Prevent Cytomegalovirus Infection in Renal Transplant Recipients. Kidney & Blood Pressure Research. 35(6). 407–416. 15 indexed citations
12.
Eiselt, Jaromír, et al.. (2010). High Ferritin, but Not Hepcidin, Is Associated with a Poor Immune Response to an Influenza Vaccine in Hemodialysis Patients. Nephron Clinical Practice. 115(2). c147–c153. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Arroyo‐Sánchez Breakdown of academic impact, for papers by Noémie Lachaume Breakdown of academic impact, for papers by Christophe Masset Breakdown of academic impact, for papers by Karin Hu Breakdown of academic impact, for papers by Arnaud Guérard Breakdown of academic impact, for papers by Leela Morená Breakdown of academic impact, for papers by Victor Augusto Hamamoto Sato Breakdown of academic impact, for papers by Marie Le Breakdown of academic impact, for papers by Carlijn Jordans Breakdown of academic impact, for papers by S. Reshwan K. Malahe
Rankless by CCL
2026